The Long Run with Luke Timmerman podcast

Ep192: Kate Haviland on Following the Science to Precision Immunology

8/1/2026

The Long Run with Luke Timmerman

0:00

1:26:06

Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.

Otros episodios de "The Long Run with Luke Timmerman"

Ep192: Kate Haviland on Following the Science to Precision Immunology
8/1/2026
1:26:06
Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
15/12/2025
1:07:34
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
No te pierdas ningún episodio de “The Long Run with Luke Timmerman”. Síguelo en la aplicación gratuita de GetPodcast.
Ep190: Neil Kumar on Building a Rare Disease Drug Company
20/11/2025
1:13:12
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
12/11/2025
1:12:33
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Ep188: Art Krieg on Innate Immune System Activators for Cancer
28/10/2025
1:09:05
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Ep187: Eric Fischer on Creating a New Class of Medicines
14/10/2025
1:05:48
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
29/9/2025
1:02:33
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
17/9/2025
1:05:47
Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies
28/8/2025
1:50:23
Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
6/8/2025
56:23
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.

Más episodios

Descubre los mejores podcast en la aplicación gratuita de GetPodcast.

Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.

Ep192: Kate Haviland on Following the Science to Precision Immunology

The Long Run with Luke Timmerman

Otros episodios de "The Long Run with Luke Timmerman"

Ep192: Kate Haviland on Following the Science to Precision Immunology

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

Ep190: Neil Kumar on Building a Rare Disease Drug Company

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Ep187: Eric Fischer on Creating a New Class of Medicines

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors